Deepak Pruthi, MD
Urology · San Antonio, TXNPI 1043664386
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (51.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 74.5% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $4,584, more than ten times the $105 reported in 2019.
Across 22 payments — averaging $266.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Histosonics, Inc.$589
- Boston Scientific$470
- Johnson & Johnson$146
- Urogen Pharma, Inc.$125
- Travere Therapeutics, Inc.$105
- plus $56 from 1 others
What the payments were for
- Travel & lodging$1,70429%
- Food & beverage$1,15220%
- Education$3,00051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $4,365 |
| Histosonics, Inc. | 1 | $589 |
| Boston Scientific | 4 | $470 |
| Johnson & Johnson | 1 | $146 |
| Urogen Pharma, Inc. | 2 | $125 |
| Travere Therapeutics, Inc. | 2 | $105 |
| Hologic Sales And Service, LLC | 2 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DA VINCI SP$3,000
- Da Vinci Surgical System$1,096
- AMS 700$131
- JELMYTO$104
How this compares
$5,856 in reported general payments places this provider in the 60th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 18 | $15,111 |
| GemtesaVibegron | 11 | $5,231 |
| Tamsulosin Hcl | 140 | $2,197 |
| Finasteride | 135 | $2,133 |
| Trospium Chloride | 25 | $1,413 |
| Bicalutamide | 18 | $636 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $607 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 19 | $296 |
| Testosterone Cypionate | 14 | $158 |
| Alendronate Sodium | 14 | $103 |
Paid to pharmacies, not to this prescriber.
Other urology in San Antonio
- Daniel SaltzsteinSan Antonio$547K
- Leroy JonesSan Antonio$506K
- Jose de la CerdaSan Antonio$278K
- Naveen KellaSan Antonio$84K
- Christopher CantrillSan Antonio$73K
- Robert SvatekSan Antonio$51K
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.